🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/07/2004 | 49,78 | 52,14 | 48,85 | 50,94 | +1,11% | 6,62% | 188.833 |
| 21/07/2004 | 54,09 | 54,50 | 50,04 | 50,38 | -5,81% | 8,24% | 340.611 |
| 20/07/2004 | 51,35 | 53,71 | 51,02 | 53,49 | +4,15% | 5,25% | 215.256 |
| 19/07/2004 | 51,92 | 52,25 | 49,78 | 51,35 | -1,30% | 4,76% | 277.453 |
| 16/07/2004 | 53,30 | 53,90 | 51,77 | 52,03 | -2,39% | 4,00% | 156.212 |
| 15/07/2004 | 53,86 | 54,20 | 53,00 | 53,30 | -0,90% | 2,22% | 170.372 |
| 14/07/2004 | 52,36 | 54,35 | 51,99 | 53,79 | +2,57% | 4,50% | 265.484 |
| 13/07/2004 | 52,40 | 53,45 | 51,88 | 52,44 | +1,08% | 3,00% | 284.319 |
| 12/07/2004 | 54,09 | 54,09 | 50,83 | 51,88 | -2,12% | 6,02% | 422.364 |
| 09/07/2004 | 50,53 | 53,75 | 49,22 | 53,00 | +2,53% | 8,96% | 492.548 |
| 08/07/2004 | 54,09 | 54,27 | 51,20 | 51,69 | -4,03% | 5,67% | 302.673 |
| 07/07/2004 | 55,40 | 56,07 | 51,50 | 53,86 | -3,03% | 8,24% | 965.273 |
| 06/07/2004 | 60,90 | 61,05 | 55,43 | 55,55 | -9,62% | 9,22% | 558.325 |
| 02/07/2004 | 61,80 | 63,22 | 60,94 | 61,46 | -0,30% | 3,69% | 371.362 |
| 01/07/2004 | 64,94 | 65,05 | 61,65 | 61,65 | -5,24% | 5,24% | 213.386 |
| 30/06/2004 | 65,13 | 65,24 | 62,47 | 65,05 | +0,06% | 4,25% | 376.652 |
| 29/06/2004 | 64,64 | 65,65 | 63,44 | 65,02 | +2,12% | 3,42% | 371.629 |
| 28/06/2004 | 68,16 | 69,36 | 63,59 | 63,67 | -6,07% | 8,46% | 305.318 |
| 25/06/2004 | 65,32 | 67,82 | 65,32 | 67,79 | +1,97% | 3,84% | 256.240 |
| 24/06/2004 | 67,07 | 67,37 | 65,95 | 66,48 | -0,28% | 2,12% | 149.346 |
| 23/06/2004 | 63,63 | 66,96 | 62,55 | 66,66 | +4,83% | 6,94% | 366.553 |
| 22/06/2004 | 62,43 | 63,63 | 61,50 | 63,59 | +1,74% | 3,42% | 211.302 |
| 21/06/2004 | 64,38 | 64,57 | 62,25 | 62,51 | -2,96% | 3,60% | 181.700 |
| 18/06/2004 | 65,09 | 65,50 | 62,81 | 64,42 | -1,15% | 4,14% | 326.077 |
| 17/06/2004 | 66,59 | 66,81 | 64,87 | 65,17 | -2,14% | 2,92% | 162.037 |
| 16/06/2004 | 65,73 | 67,41 | 64,57 | 66,59 | +1,25% | 4,33% | 206.146 |
| 15/06/2004 | 66,44 | 67,00 | 64,72 | 65,76 | +0,46% | 3,44% | 204.917 |
| 14/06/2004 | 64,27 | 65,76 | 63,82 | 65,46 | +1,92% | 3,03% | 212.665 |
| 10/06/2004 | 66,10 | 66,48 | 63,52 | 64,23 | -2,44% | 4,47% | 288.567 |
| 09/06/2004 | 69,47 | 69,92 | 65,35 | 65,84 | -6,04% | 6,57% | 302.887 |